Essential Reads: Prenatal Exposure to Benzodiazepines and Neurodevelopmental Outcomes
The largest study to date observes no increase in risk of autism or ADHD in children with prenatal exposure to benzodiazepines.
Essential Reads: Peer Support Interventions for Perinatal Depression
Peer support interventions can reduce the incidence of postpartum depression and the severity of depressive symptoms.
Essential Reads: Why Non-Randomized Studies Fall Short When Assessing Reproductive Safety
All of our information on the reproductive safety of medications comes from non-randomized studies. However, many of these studies fail to take into consideration other factors associated with maternal psychiatric illness which may also affect outcomes.
Toward a Better Understanding of Opioid Use During Pregnancy
Opioid use during pregnancy co-occurs with other variables that are associated with worse outcomes in children, specifically maternal depression and the use of alcohol, tobacco, and other drugs.
Happy Thanksgiving from the MGH Center for Women’s Mental Health
Happy Thanksgiving from the MGH Center for Women's Mental Health
Suicidal Ideation Common in Women Seeking Treatment for Premenstrual Dysphoric Disorder
In this population seeking treatment for PMDD, suicidal ideation is very common, affecting about 40% of the women.
Weekly Roundup for NOVEMBER 11, 2022: Recent Publications in Women’s Mental Health
Every week we review the most recent publications in women’s mental health.
Essential Reads: What You Need to Know About Bioidentical Hormone Therapy for Menopausal Symptoms
While many peri- and post-menopausal women request bioidentical hormones, there is no data to suggest that bioidential hormones are safer or more effective than FDA-approved hormone replacement therapies.
Next MGH Online Course on Women’s Mental Health Starts November: Register Today
Our next course begins on November 14, 2022, and registration is available through the MGH Psych Academy now! This online course will focus on the diagnosis and treatment of psychiatric disorders in women across the [...]
Largest Study Ever Shows No Increase in Risk of Neurodevelopmental Disorders in Kids Exposed to Antidepressants In Utero
Analyzing data from nearly 150,000 children with prenatal antidepressant exposure in two healthcare databases, a recent study finds no association between prenatal exposure to antidepressants and risk for neurodevelopmental disorders.